Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: a phase 3 randomized controlled trials based meta-analysis
PaperCitations, authors & open-access status
The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: a phase 3 randomized controlled trials based meta-analysis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 9 citations, 2025 year and gold oa status.
9
Citations
2025
Year
gold
OA Status